Document Detail

Local and systemic zymogen activation in human acute pancreatitis.
MedLine Citation:
PMID:  11025364     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Activation of trypsinogen and phospholipase A(2) is an early event in pancreatic inflammation, but little is known about zymogen activation and the severity of human pancreatitis. METHODS: Using a new fluoroimmunoassay we measured trypsinogen activation peptide (TAP) and phospholipase A(2) activation peptide (PROP) in plasma and ascites in 25 patients with acute pancreatitis. TAP, PROP, Pro-PROP and pancreatic PLA(2)-I were measured in plasma for 14 days and in pancreatic necroses, ascitic fluid and pleural effusions. RESULTS: All 16 patients with severe acute pancreatitis (SAP) had pancreatic necrosis, 10 developed systemic complications like sepsis, pulmonary or renal failure, 6 had infected necrosis, and 4 died. All 9 patients with mild pancreatitis (MAP) survived. Plasma TAP on admission was higher in patients with SAP than in those with MAP and increased in infected necroses. It did not correlate with systemic complications. Systemic PROP was not increased in complicated courses but was significantly higher in patients with MAP than in those with SAP on admission. Pro-PROP was higher in patients with SAP than in those with MAP but was not correlated with systemic complications. Plasma pancreatic PLA(2)-I was increased but not different in patients with SAP and those with MAP. In patients with pancreatic necrosis, TAP and PROP were highest, while in those with post-acute pancreatic abscess, only PROP and Pro-PROP were high. In patients with pleural effusion, TAP was low and PROP/ Pro-PROP were high. CONCLUSION: Trypsinogen and PLA(2)-I activation are early events in acute pancreatitis and the activation peptides can be detected in plasma. In the pancreas, trypsinogen activation is accompanied by PLA(2)-I activation in patients with pancreatic necrosis. However, in our study, organ complications in SAP patients was not associated with increased plasma PROP.
J M Mayer; B Rau; M Siech; H G Beger
Related Documents :
512104 - Contrast enhancement of the pancreas in computed tomography.
742604 - Elevated serum amylase activity in the absence of clinical pancreatic or salivary gland...
16167144 - Surgical influence of pancreatectomy on the function and count of circulating dendritic...
2729774 - Adult nesidioblastosis. an unusual cause of fasting hypoglycemia.
2965854 - Identification of high-risk patients with silent myocardial ischemia after percutaneous...
8219544 - Traumatic occipitoatlantal dislocations.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Digestion     Volume:  62     ISSN:  0012-2823     ISO Abbreviation:  Digestion     Publication Date:  2000  
Date Detail:
Created Date:  2000-11-13     Completed Date:  2001-01-11     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0150472     Medline TA:  Digestion     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  164-70     Citation Subset:  IM    
Copyright Information:
Copyright 2000 S. Karger AG, Basel.
Department of General Surgery, University Hospital of Ulm, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Aged, 80 and over
Enzyme Induction
Middle Aged
Oligopeptides / analysis,  pharmacology
Pancreatitis / enzymology*
Phospholipases A / metabolism*
Pleural Effusion
Proteins / analysis,  pharmacology
Trypsinogen / metabolism*
Reg. No./Substance:
0/Oligopeptides; 0/Proteins; 0/phospholipase A2-activating protein; 0/trypsinogen activation peptide; 9002-08-8/Trypsinogen; EC 3.1.1.-/Phospholipases A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Induction of artificial fat maldigestion by tetrahydrolipstatin assessed by the (13)C-hiolein breath...
Next Document:  Low frequency of p16(INK4a) alterations in insulinomas.